Innovations in modeling influenza virus infections in the laboratory

Trends in Microbiology

Volumn 20, Issue 6, 2012, Pages 275-281

  Gustin, Kortney M ^a   Belser, Jessica A ^a   Katz, Jacqueline M ^a   Tumpey, Terrence M ^a   Maines, Taronna R ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Animal models; Bioaerosol; Influenza virus; Transmission

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE; LIVE VACCINE;

ADENOVIRUS; AEROSOL; CORONAVIRUS; COUGHING; DISEASE SEVERITY; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION RATE; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; INOCULATION; LABORATORY; LABORATORY INFECTION; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; PANDEMIC INFLUENZA; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; REVIEW; RHINOVIRUS; SARS CORONAVIRUS; SEASONAL VARIATION; UPPER RESPIRATORY TRACT INFECTION; VIRAL GENETICS; VIRUS ATTACHMENT; VIRUS SHEDDING; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CYTOLOGICAL TECHNIQUES; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE;

ANIMALIA; ORTHOMYXOVIRIDAE;

EID: 84861658780     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.03.006     Document Type: Review

References (80)

1. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev. Infect. Dis. 1991, 13:S454-S462.
2. Whimbey E., et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin. Infect. Dis. 1996, 22:778-782.
3. Williams J.V., et al. A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J. Infect. Dis. 2005, 192:1061-1065.
4. Sondik, E.J. and Madans, J.H. (2011) Summary Health Statistics for the U.S. Population: National Health Interview Survey, 2010. Vital Health Stat Series No. 10 (251). National Center for Health Statistics.
5. Monto A.S., Sullivan K.M. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol. Infect. 1993, 110:145-160.
6. Hussain I.R., Johnston S.L. Viral Infections. Upper and Lower Respiratory Disease 2003, 187-222. Marcel Dekker. J. Corren (Ed.).
7. Pavia A.T. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin. Infect. Dis. 2011, 52:S284-S289.
8. Peiris J.S., et al. Severe acute respiratory syndrome. Nat. Med. 2004, 10:S88-S97.
9. Simonsen L., et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 1998, 178:53-60.
10. Miller M.A., et al. The signature features of influenza pandemics-implications for policy. N. Engl. J. Med. 2009, 360:2595-2598.
11. Cauchemez S., et al. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N. Engl. J. Med. 2009, 361:2619-2627.
12. Szucs T. The socio-economic burden of influenza. J. Antimicrob. Chemother. 1999, 44:11-15.
13. Thompson W.W., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
14. Riley S., et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med. 2011, 8:e1000442.
15. Johnson N.P., Mueller J. Updating the accounts: global mortality of the 1918-1920 " Spanish" influenza pandemic. Bull. Hist. Med. 2002, 76:105-115.
16. Tellier R. Aerosol transmission of influenza A virus: a review of new studies. J. R. Soc. Interface 2009, 6:S783-S790.
17. Monto A.S. Occurrence of respiratory virus: time, place and person. Pediatr. Infect. Dis. J. 2004, 23:S58-S64.
18. Chowell G., et al. Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J. Infect. Dis. 2010, 202:567-575.
19. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 2006, 12:9-14.
20. Dowell S.F. Seasonal variation in host susceptibility and cycles of certain infectious diseases. Emerg. Infect. Dis. 2001, 7:369-374.
21. Lofgren E., et al. Influenza seasonality: underlying causes and modeling theories. J. Virol. 2007, 81:5429-5436.
22. Eccles R. An explanation for the seasonality of acute upper respiratory tract viral infections. Acta Otolaryngol. 2002, 122:183-191.
23. Polozov I.V., et al. Progressive ordering with decreasing temperature of the phospholipids of influenza virus. Nat. Chem. Biol. 2008, 4:248-255.
24. Minhaz Ud-Dean S.M. Structural explanation for the effect of humidity on persistence of airborne virus: seasonality of influenza. J. Theor. Biol. 2010, 264:822-829.
25. Harper G.J. Airborne micro-organisms: survival tests with four viruses. J. Hyg. (Lond.) 1961, 59:479-486.
26. Hemmes J.H., et al. Virus survival as a seasonal factor in influenza and polimyelitis. Nature 1960, 188:430-431.
27. Schaffer F.L., et al. Survival of airborne influenza virus: effects of propagating host, relative humidity, and composition of spray fluids. Arch. Virol. 1976, 51:263-273.
28. Tang J.W. The effect of environmental parameters on the survival of airborne infectious agents. J. R. Soc. Interface 2009, 6:S737-S746.
29. Tamerius J., et al. Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ. Health Perspect. 2011, 119:439-445.
30. Tseng C.T., et al. Apical entry and release of severe acute respiratory syndrome-associated coronavirus in polarized Calu-3 lung epithelial cells. J. Virol. 2005, 79:9470-9479.
31. Thompson C.I., et al. Infection of human airway epithelium by human and avian strains of influenza a virus. J. Virol. 2006, 80:8060-8068.
32. Zeng H., et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J. Virol. 2007, 81:12439-12449.
33. Chan M.C., et al. Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells. Respir. Res. 2009, 10:102.
34. Matrosovich M.N., et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4620-4624.
35. Belser J.A., et al. Ocular tropism of influenza A viruses: identification of H7 subtype-specific host responses in human respiratory and ocular cells. J. Virol. 2011, 85:10117-10125.
36. Shinya K., et al. Avian flu: influenza virus receptors in the human airway. Nature 2006, 440:435-436.
37. van Riel D., et al. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am. J. Pathol. 2010, 176:1614-1618.
38. Nicholls J.M., et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat. Med. 2007, 13:147-149.
39. van Riel D., et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 2007, 171:1215-1223.
40. van Riel D., et al. H5N1 virus attachment to lower respiratory tract. Science (New York, N. Y.) 2006, 312:399.
41. Piazza F.M., et al. Attachment of influenza A virus to ferret tracheal epithelium at different maturational stages. Am. J. Respir. Cell Mol. Biol. 1991, 4:82-87.
42. Van Poucke S.G., et al. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol. J. 2010, 7:38.
43. Hoke C.H., et al. Comparison of several wild-type influenza viruses in the ferret tracheal organ culture system. Rev. Infect. Dis. 1979, 1:946-954.
44. Roberts K.L., et al. Lack of transmission of a human influenza virus with avian receptor specificity between ferrets is not due to decreased virus shedding but rather a lower infectivity in vivo. J. Gen. Virol. 2011, 92:1822-1831.
45. Jayaraman A., et al. Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract. PLoS ONE 2012, 7:e27517.
46. Gustin K.M., et al. Influenza virus aerosol exposure and analytical system for ferrets. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:8432-8437.
47. Killingley B., et al. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect. Dis. 2011, 11:879-886.
48. Kuiken T., et al. Comparative pathology of select agent influenza A virus infections. Vet. Pathol. 2010, 47:893-914.
49. Matsuoka Y., et al. The mouse model for influenza. Curr. Protoc. Microbiol. 2009, Chapter 15, Unit 15G 13.
50. Belser J.A., et al. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv. Virus Res. 2009, 73:55-97.
51. Lowen A.C., et al. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathogens 2007, 3:1470-1476.
52. Mubareka S., et al. Transmission of influenza virus via aerosols and fomites in the guinea pig model. J. Infect. Dis. 2009, 199:858-865.
53. Lowen A.C., et al. High temperature (30°C) blocks aerosol but not contact transmission of influenza virus. J. Virol. 2008, 82:5650-5652.
54. Van Hoeven N., et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. J. Virol. 2009, 83:2851-2861.
55. Matsuoka Y., et al. The ferret model for influenza. Curr. Protoc. Microbiol. 2009, Chapter 15, Unit 15G 12.
56. Maines T.R., et al. Local innate immune responses and influenza virus transmission and virulence in ferrets. J. Infect. Dis. 2012, 205:474-485.
57. Leigh M.W., et al. Receptor specificity of influenza virus influences severity of illness in ferrets. Vaccine 1995, 13:1468-1473.
58. Belser J.A., et al. Influenza A virus transmission: contributing factors and clinical implications. Expert Rev. Mol. Med. 2010, 12:e39.
59. Papineni R.S., Rosenthal F.S. The size distribution of droplets in the exhaled breath of healthy human subjects. J. Aerosol Med. 1997, 10:105-116.
60. Fairchild C.I., Stampfer J.F. Particle concentration in exhaled breath. Am. Ind. Hyg. Assoc. J. 1987, 48:948-949.
61. Lindsley W.G., et al. Measurements of airborne influenza virus in aerosol particles from human coughs. PLoS ONE 2010, 5:e15100.
62. Fabian P., et al. An optimized method to detect influenza virus and human rhinovirus from exhaled breath and the airborne environment. J. Environ. Monit. 2009, 11:314-317.
63. Cao G., et al. Development of an improved methodology to detect infectious airborne influenza virus using the NIOSH bioaerosol sampler. J. Environ. Monit. 2011, 13:3321-3328.
64. Lakdawala S.S., et al. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 2011, 7:e1002443.
65. Respiratory Deposition. Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles 1999, John Wiley & Sons. W.C. Hinds (Ed.).
66. Wolff R.K., Dorato M.A. Toxicologic testing of inhaled pharmaceutical aerosols. Crit. Rev. Toxicol. 1993, 23:343-369.
67. Vinegar A., et al. Pulmonary physiology of the ferret and its potential as a model for inhalation toxicology. Lab. Anim. Sci. 1985, 35:246-250.
68. Cheng Y.S., et al. Lung deposition of droplet aerosols in monkeys. Inhal. Toxicol. 2008, 20:1029-1036.
69. Bray M., et al. Molecular imaging of influenza and other emerging respiratory viral infections. J. Infect. Dis. 2011, 203:1348-1359.
70. McCullers J.A., Bartmess K.C. Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J. Infect. Dis. 2003, 187:1000-1009.
71. Bodewes R., et al. Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am. J. Pathol. 2011, 179:30-36.
72. van den Brand J.M., et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J. Infect. Dis. 2010, 201:993-999.
73. Belser J.A., et al. Ocular infection of mice with influenza A (H7) viruses: a site of primary replication and spread to the respiratory tract. J. Virol. 2009, 83:7075-7084.
74. Aamir U.B., et al. Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan. Virology 2009, 390:212-220.
75. Smith J.H., et al. Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis. Viral Immunol. 2011, 24:131-142.
76. Wilson S.Z., et al. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob. Agents Chemother. 1980, 17:642-648.
77. Jemski J.V., Walker J.S. Aerosol vaccination of mice with a live, temperature-sensitive recombinant influenza virus. Infect. Immun. 1976, 13:818-824.
78. Lednicky J.A., et al. Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A/Vietnam/1203/2004 (H5N1). Virol. J. 2010, 7:231.
79. Macinnes H., et al. Transmission of aerosolized seasonal H1N1 influenza A to ferrets. PLoS ONE 2011, 6:e24448.
80. Alford R.H., et al. Human influenza resulting from aerosol inhalation. Proc. Soc. Exp. Biol. Med. 1966, 122:800-804.